Ultragenyx Pharmaceutical | RARE - أرباح التشغيل





أرباح التشغيل تغيير تاريخ
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Agios Pharmaceuticals USD -110.02M 11.55M 2026-03
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Immunic USD -23.33M 2.67M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Kyowa Hakko Kirin JPY 22.26B 12.74B 2026-06
MacroGenics USD -33.44M 21.34M 2026-03
Moderna USD -815M 573M 2026-06
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06